Update on Hepatitis C Elimination in 2025
Nov
08
2025
Convention Center: Room 207, Level 2
11:00 AM
- 12:30 PM
World Class Speakers
Description
In this joint session with the European Society of Clinical Microbiology and Infectious Diseases Study Group for Viral Hepatitis, experts review and discuss the most updated information on hepatitis C elimination in the United States and other countries. Presenters explore obstacles to execution of hepatitis C elimination plans and strategies to overcome these challenges.
Journey Maps
Presentations
11:00 AM
- 11:20 AM
Oct
09
2026
Convention Center - Room 207, Level 2
Hepatitis C Elimination in North America: What Should We Focus On?
Brian Conway, MD, FRCPC
, Presenter
Hepatitis
Public Health
11:20 AM
- 11:40 AM
Oct
09
2026
Convention Center - Room 207, Level 2
Hepatitis C Elimination Across Continents: Successes, Challenges, and Lessons Learned
Oana Sandulescu, MD, PhD
, Presenter
Hepatitis
Public Health
11:40 AM
- 12:00 PM
Oct
09
2026
Convention Center - Room 207, Level 2
Hepatitis C Virus Infection Among International Refugees and Immigrants
Norah Terrault, MD, MPH, FAASLD
, Presenter
Hepatitis
Public Health
12:00 PM
- 12:30 PM
Oct
09
2026
Convention Center - Room 207, Level 2
Q&A
John W Ward, MD
, Moderator
Hepatitis
Public Health
Objectives
- Discuss the status of national hepatitis C elimination programs in various countries.
- Identify the obstacles to the hepatitis C elimination plans and outline opportunities for enhancing or developing the ongoing strategies.
- Review the unique challenges that international refugees and immigrants face in accessing hepatitis C care and discuss strategies to overcome these barriers to care.
Chair
Harrys A Torres, MD, FAASLD
The University of Texas MD Anderson Cancer Center